NOS2 and prostate cancer: Cell lines derived from various human malignancies, including pancreatic, colorectal, and prostate cancer, melanoma, and myeloma were all effectively killed by activated macrophages in an iNOS-dependent manner (Table 1), confirming that a wide range of cancer cell types are susceptible to NO-mediated cell death.